Literature DB >> 22376259

Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.

John Kwagyan1, Victor Apprey, Hassan Ashktorab.   

Abstract

Single nucleotide polymorphisms (SNPs) in the promoter and untranslated region of cyclooxygenase (COX)-2, an inducible enzyme responsible for the synthesis of prostaglandins, have been reported to modulate the risk for many human cancers. We performed comprehensive linkage disequilibrium (LD) and haplotype analyses of 13 single nucleotide polymorphisms of the COX-2 gene and examined its susceptibility to adenoma development in 72 African American cases and 142 controls. Results revealed significant variation in LD patterns with consequence for adenoma development. Two distinct haplotype blocks were identified; one block covered the coding regions of exon 1, introns and a section of the 3'-unstranslated region (3'-UTR), whereas the second block resided solely in the 3'-UTR region. A haplotype in block 1 increased the risk of adenoma development by threefold (odds ratio [OR]= 2.9, confidence interval [CI]= 1.8-3.7, P= 0.002). Regression analysis showed, increase in copies of minor alleles of 6,064(T>C) polymorphism associated with increased odds of adenoma development by 80% (OR = 1.80, CI = 1.09-3.21, P= 0.034), 10,848(G>A) by 84% (OR = 1.84, CI = 1.05-3.23, P= 0.034) and 10,935(A>G) by 32% (OR = 1.32, CI = 1.12-3.69, P= 0.036). These results support the hypothesis that COX-2 gene might play a role in the etiology of colon cancer and warrant further investigation in other cancers. Besides, these variations should be taken into account for disease-based association studies in which the COX-2 polymorphism is considered as a candidate gene. Clin Trans Sci 2012; Volume 5: 60-64.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22376259      PMCID: PMC3618970          DOI: 10.1111/j.1752-8062.2011.00373.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  26 in total

Review 1.  Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

Authors:  Daniel L Simmons; Regina M Botting; Timothy Hla
Journal:  Pharmacol Rev       Date:  2004-09       Impact factor: 25.468

2.  Lack of association between polymorphisms in inflammatory genes and lung cancer risk.

Authors:  Daniele Campa; Rayjean J Hung; Dana Mates; David Zaridze; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Eleonóra Fabiánová; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Paolo Boffetta; Paul Brennan; Federico Canzian
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

3.  A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population.

Authors:  Z Hu; X Miao; H Ma; X Wang; W Tan; Q Wei; D Lin; H Shen
Journal:  Lung Cancer       Date:  2005-04       Impact factor: 5.705

4.  Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.

Authors:  Sokbom Kang; Yong Beom Kim; Moon-Hong Kim; Kyung-Sik Yoon; Jae Weon Kim; Noh Hyun Park; Yong Sang Song; Daehee Kang; Keun-Young Yoo; Soon Beom Kang; Hyo Pyo Lee
Journal:  Cancer Lett       Date:  2005-01-10       Impact factor: 8.679

5.  Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.

Authors:  Xuemei Zhang; Xiaoping Miao; Wen Tan; Baitang Ning; Zhihua Liu; Yuan Hong; Wenguang Song; Yongli Guo; Xinyu Zhang; Yan Shen; Boqin Qiang; Fred F Kadlubar; Dongxin Lin
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

Review 6.  Prostaglandin synthase 2.

Authors:  H R Herschman
Journal:  Biochim Biophys Acta       Date:  1996-01-05

7.  PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.

Authors:  Cornelia M Ulrich; John Whitton; Joon-Ho Yu; Justin Sibert; Rachel Sparks; John D Potter; Jeannette Bigler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

8.  Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.

Authors:  Christine L E Siezen; Astrid I M van Leeuwen; Nicolien R Kram; Manon E M Luken; Henk J van Kranen; Ellen Kampman
Journal:  Carcinogenesis       Date:  2004-11-18       Impact factor: 4.944

9.  Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.

Authors:  I U Ali; B T Luke; M Dean; P Greenwald
Journal:  Br J Cancer       Date:  2005-10-17       Impact factor: 7.640

10.  Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.

Authors:  Jung Min Park; Jin Eun Choi; Myung Hwa Chae; Won Kee Lee; Sung Ick Cha; Ji-Woong Son; Chang Ho Kim; Sin Kam; Young Mo Kang; Tae Hoon Jung; Jae Yong Park
Journal:  BMC Cancer       Date:  2006-03-17       Impact factor: 4.430

View more
  3 in total

1.  Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells.

Authors:  Feng-Jun Guo; Jing-Yan Tian; Yue-Mei Jin; Ling Wang; Rui-Qi Yang; Man-Hua Cui
Journal:  Mol Med Rep       Date:  2014-10-21       Impact factor: 2.952

2.  Genetic variants in RET, ARHGEF3 and CTNNAL1, and relevant interaction networks, contribute to the risk of Hirschsprung disease.

Authors:  Yang Wang; Qian Jiang; Hao Cai; Ze Xu; Wenjie Wu; Beilin Gu; Long Li; Wei Cai
Journal:  Aging (Albany NY)       Date:  2020-03-06       Impact factor: 5.682

3.  Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.

Authors:  Qiliu Peng; Shi Yang; Xianjun Lao; Weizhong Tang; Zhiping Chen; Hao Lai; Jian Wang; Jingzhe Sui; Xue Qin; Shan Li
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.